Bharat Forge Stock: Defence Orders and US-India Trade Deal See Brokers Up Targets

A 102% surge in defence revenue and Rs 11,130 crore executable order book offset margin pressure from tariffs as brokers upgrade ratings on multi-year growth visibility Bharat Forge is riding a defence-driven... Read more »

Apollo Hospitals Stock: HealthCo Demerger and 1,500-Bed Expansion Drive Multi-Year Growth

Strong Q3 performance and strategic restructuring push brokerages to maintain buy ratings with 20% upside as hospital margins hit 24.8% and pharmacy business nears breakeven Apollo Hospitals Enterprise is executing a transformation... Read more »

Infosys Has a New AI Playbook

Infosys tells investors exactly how it plans to win the AI era – and analysts reckon the upside case is good Infosys held its AI Investor Day recently, and the message from... Read more »

Torrent Pharma Stock: A Strong Quarter

Torrent Pharma delivered a textbook quarter — revenues up 18 per cent year-on-year to Rs 33 billion, profits climbing 26 per cent to Rs 6.4 billion, and EBITDA margins nudging up 40... Read more »

Britannia Industries Stock: Brokers See Up to 21% Upside as New CEO Bets Big on Brands

A GST-driven margin surprise and accelerating sales has brokerages agree the growth story has legs Britannia Industries is back in a sweet spot. The country’s largest biscuit maker delivered a margin performance... Read more »

IPCA Laboratories Sees Strong Margin Expansion; Brokers See 15-28% Upside

Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls  IPCA Laboratories has emerged as a growth story in India’s pharmaceutical sector with two leading brokerages issuing... Read more »

Four Mainboard IPOs Worth Rs 5,700 Crore Line Up After Fractal, Aye Finance Disappoint on Debut

Four main board IPOs have lined up IPOs, but will they see enough subscription? The primary market is bracing for a busy fortnight with four mainboard initial public offerings aggregating Rs 5,700... Read more »

Can Indian IT Stocks Survive The AI Era?

With Nifty IT down 15% in a month and FCF yields at crisis levels, analysts ask: Is this a Kodak moment or a generational buying opportunity? The question haunting Dalal Street’s technology... Read more »

This Jewellery Firm Has Grown Revenues at 50% This Quarter

A 50% revenue surge and 400% profit jump have made analysts sit up and take notice When a mid-cap jewellery stock delivers revenue growth of 50% and profit growth north of 400%... Read more »

Lupin’s US Generics Juggernaut Delivers Another Nice Quarter — But Can the Magic Last?

Lupin has delivered the goods this quarter. When a pharmaceutical company beats estimates across revenue, margins, and profit in a single quarter, investors tend to sit up. When it does so by... Read more »